Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that Memorial S...
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...
CStone Pharmaceuticals, on 9 July 2019, announced in Suzhou, China that the first patient has been dosed in Ch...
Sangamo Therapeutics, a genomic medicine company, and Pfizer has announced updated results from the Phase 1/2 ...
Takeda, an R&D-driven, global biopharmaceutical company with a leadership position in rare diseases has announced up...
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has annou...
XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel s...
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to marke...
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announc...
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration h...
Boehringer Ingelheim and Eli Lilly and Company have announced results of a new post-hoc analysis of data from the EMPA-R...
Reistone Biopharma Company Limited (Reistone), on 14 June 2019, announced dosing of the first patient in their Phase II ...
Lumosa Therapeutics, on 13 June 2019, announced that the company is ready to commence the Phase 2 proof of concept (PoC)...
Sinovant Sciences announced on 13 June 2019, that its Clinical Trial Application (CTA) for lefamulin has been accepted b...
Terns Pharmaceuticals, Inc. and Shanghai Tuo Zhen Biological Technology Co., Ltd., on 13 June 2019, announced the launch...
Dr. Reddy’s has announced positive topline results from its Phase 2b study of PPC-06 (formerly referred to as...
